{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T17:15:39Z","timestamp":1715620539515},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s40121-015-0066-x","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T08:00:42Z","timestamp":1432022442000},"page":"213-218","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolated from Blood Samples and Antibiotic Utilization in a University Hospital in Japan"],"prefix":"10.1007","volume":"4","author":[{"given":"Ito","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumie","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Higurashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Okugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoji","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,20]]},"reference":[{"key":"66_CR1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jhin.2009.04.020","volume":"73","author":"KG Kerr","year":"2009","unstructured":"Kerr KG, Snelling AM. Pseudomonas aeruginosa: a formidable and ever-present adversary. J Hosp Infect. 2009;73:338\u201344.","journal-title":"J Hosp Infect."},{"key":"66_CR2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archinte.160.4.501","volume":"160","author":"I Chatzinikolaou","year":"2000","unstructured":"Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV, Tarrand JJ, Samonis G. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes. Arch Intern Med. 2000;160:501\u20139.","journal-title":"Arch Intern Med"},{"key":"66_CR3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13613-014-0034-8","volume":"4","author":"N Culshaw","year":"2014","unstructured":"Culshaw N, Glover G, Whiteley C, et al. Healthcare-associated bloodstream infections in critically ill patients: descriptive cross-sectional database study evaluating concordance with clinical site isolates. Ann Intensive Care. 2014;4:34.","journal-title":"Ann Intensive Care."},{"key":"66_CR4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s100960000410","volume":"19","author":"G Maschmeyer","year":"2000","unstructured":"Maschmeyer G, Braveny I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis. 2000;19:915\u201325.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"66_CR5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1469-0691.2007.01681.x","volume":"13","author":"N Mesaros","year":"2007","unstructured":"Mesaros N, Nordmann P, Plesiat P, et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect. 2007;13:560\u201378.","journal-title":"Clin Microbiol Infect"},{"key":"66_CR6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159\u201377.","journal-title":"Clin Infect Dis."},{"key":"66_CR7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijantimicag.2005.08.016","volume":"26","author":"PR Hsueh","year":"2005","unstructured":"Hsueh PR, Chen WH, Luh KT. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991\u20132003 at a university hospital in Taiwan. Int J Antimicrob Agents. 2005;26:463\u201372.","journal-title":"Int J Antimicrob Agents"},{"key":"66_CR8","doi-asserted-by":"crossref","first-page":"e78604","DOI":"10.1371\/journal.pone.0078604","volume":"8","author":"J Xu","year":"2013","unstructured":"Xu J, Duan X, Wu H, Zhou Q. Surveillance and correlation of antimicrobial usage and resistance of Pseudomonas aeruginosa: a hospital population-based study. PLoS One. 2013;8:e78604.","journal-title":"PLoS One"},{"key":"66_CR9","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2169\/internalmedicine.49.3360","volume":"49","author":"Y Fukushima","year":"2010","unstructured":"Fukushima Y, Fukushima F, Kamiya K, et al. Relation between the antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from respiratory specimens and antimicrobial use density (AUD) from 2005 through 2008. Intern Med (Tokyo, Japan). 2010;49:1333\u201340.","journal-title":"Intern Med (Tokyo, Japan)"},{"key":"66_CR10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jac\/dkh039","volume":"53","author":"AH Mutnick","year":"2004","unstructured":"Mutnick AH, Rhomberg PR, Sader HS, Jones RN. Antimicrobial usage and resistance trend relationships from the MYSTIC programme in North America (1999\u20132001). J Antimicrob Chemother. 2004;53:290\u20136.","journal-title":"J Antimicrob Chemother."},{"key":"66_CR11","unstructured":"Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. CLSI document M100-S23. Wayne: Clinical and Laboratory Standards Institute; 2013."},{"key":"66_CR12","unstructured":"WHO Collaborating Centre for drug statistics methodology, definition and general considerations. http:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/ . Accessed May 7, 2015."},{"key":"66_CR13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhin.2012.10.005","volume":"83","author":"A Nakamura","year":"2013","unstructured":"Nakamura A, Miyake K, Misawa S, et al. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa. J Hosp Infect. 2013;83:153\u20135.","journal-title":"J Hosp Infect."},{"issue":"Suppl 1","key":"66_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12427","volume":"20","author":"E Tacconelli","year":"2014","unstructured":"Tacconelli E, Cataldo MA, Dancer SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20(Suppl 1):1\u201355.","journal-title":"Clin Microbiol Infect"},{"key":"66_CR15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/00365540310016646","volume":"35","author":"JM Loeffler","year":"2003","unstructured":"Loeffler JM, Garbino J, Lew D, Harbarth S, Rohner P. Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand J Infect Dis. 2003;35:843\u201350.","journal-title":"Scand J Infect Dis."},{"key":"66_CR16","first-page":"416426","volume":"2011","author":"D Slain","year":"2011","unstructured":"Slain D, Sarwari AR, Petros KO, et al. Impact of a multimodal antimicrobial stewardship program on Pseudomonas aeruginosa susceptibility and antimicrobial use in the intensive care unit setting. Crit Care Res Pract. 2011;2011:416426.","journal-title":"Crit Care Res Pract."},{"key":"66_CR17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/528811","volume":"29","author":"D Jonas","year":"2008","unstructured":"Jonas D, Meyer E, Schwab F, Grundmann H. Genodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units. Infect Control Hosp Epidemiol. 2008;29:350\u20137.","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-015-0066-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T07:54:19Z","timestamp":1498204459000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40121-015-0066-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,20]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["66"],"URL":"https:\/\/doi.org\/10.1007\/s40121-015-0066-x","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,20]]}}}